跳至主要内容
临床试验/NCT00050050
NCT00050050已完成1 期

CBT for Residual ADHD Symptoms in Adults

Massachusetts General Hospital2 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2001年9月最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
已完成
入组人数
40
试验地点
2
主要终点
ADHD symptoms

研究概览

简要总结

This study will determine the effectiveness of cognitive behavioral therapy (CBT) in treating the symptoms of attention deficit hyperactivity disorder (ADHD) in adults who have not responded to drug treatment.

Study hypothesis: CBT is an effective treatment for adult ADHD.

详细描述

ADHD, previously believed to be a disorder of childhood, affects as many as 5 percent of adults. Adults with ADHD are at high risk for academic and occupational underachievement, relationship difficulties, and reduced quality of life. This study will determine whether CBT is more effective than drug therapy in treating ADHD symptoms in adults who have been resistant to previous drug therapies.

Participants will be randomly assigned to receive 12 to 15 weekly sessions of either CBT or drug therapy which may include new or previously taken drugs. Questionnaires will be used to assess participants' ADHD symptoms at study start and at study completion.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult ADHD of at least moderate severity
  • On current drug therapy for ADHD

排除标准

  • Depression, panic disorder, bipolar disorder, organic mental disorders, psychotic disorders, or pervasive developmental disorders
  • Current substance abuse or dependence
  • IQ less than 90
  • Suicide risk
  • History of cognitive behavioral therapy

结局指标

主要结局

ADHD symptoms

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Steven A. Safren

Director Behavioral Medicine

Massachusetts General Hospital

研究点 (2)

Loading locations...

相似试验